Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-05-30 @ 9:00 AM
Study NCT ID:
NCT06207734
Status:
RECRUITING
Last Update Posted:
2025-05-01
First Post:
2024-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DISCUSS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None